Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
T.RVX
Alternate Symbol(s):
RVXCF
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:RVX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 16, 2022 10:42am
RE:RE:RE:National Post item on RVX!!
GV,,,,,,well,,,,I am still on the fence if our misfit management team can get things correct in this trial,,,its a sure thing it wont be as positive as what DMcC is so excited about. And I do think
...more
(118)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Feb 16, 2022 10:04am
RE:RE:National Post item on RVX!!
narmac warrants expire in 2023: Warrant Symbol - RVX.WT.A Number Trading - 5,000,000 Expiration Date - June 7, 2023 Cusip - 76128M 19 9 Exercise Price - $4.60 You can't say things have not
...more
New PEA Indicates an Ultra Low-Cost Uranium Project with Huge Exploration Upside
posted Apr 26, 2024 9:00am by
Blue Sky Uranium Corp
-
|
This PEA reaffirms that the deposit is a leading low-cost uranium-vanadium project. We believe that this resurgent uranium market has a strong long-term outlook and we are therefore preparing to complete a prefeasibility study as soon as possible ...read more
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 16, 2022 9:41am
RE:National Post item on RVX!!
We are a hair away from a full year since pinocchio announced the covid trial starting with data in April/May of 2021. The June warrants were still safe and optimism was everywhere!!!,,,,however short
...more
(13)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Feb 15, 2022 3:33pm
National Post item on RVX!!
https://nationalpost-com.cdn.ampproject.org/c/s/nationalpost.com/sponsored/news-sponsored/calgary-based-biotech-firm-specializes-in-instructing-cells-to-fight-complex-diseases/wcm/a968e9af-7010-45fd
...more
(118)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Feb 15, 2022 9:50am
RE:First Patient Dosed - Jan 18
QT, the primary outcome measure is 14 days. So they should have some indication by now. How many have been dosed since Jan 18, if that was the actual date they started dosing is the unknown. G1945V
(75)
•••
QualityTest
X
View Profile
View Bullboard History
Post by
QualityTest
on Feb 15, 2022 8:25am
First Patient Dosed - Jan 18
Given that patients are dosed for 28 days, we're coming up to the point in time where RVX will be able to see the full effects after patients have completed the trial. By the time we hear from DM
...more
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 14, 2022 10:19am
RE:Silence
QT,,,this is on the QT,,,,, you dont want pinocchio to open his pie hole or we will certainly get wholloped,,,its part of the history around this compnay,,,what they think it supportive news actually
...more
(75)
•••
QualityTest
X
View Profile
View Bullboard History
Post by
QualityTest
on Feb 14, 2022 8:37am
Silence
Shite. I thought we were going to get an announcement of a CC this week this morn. DM keeping his mouth shut for this long isn't a good sign. Down we go today.
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 12, 2022 5:22pm
RE:RE:Our blockbuster,,,,,
,,,where would apabetalone stnad in Canada,, even if the 100 patient trial is successful,,,,,possibly in the bleachers,,,,,, I think the Governement has signed contracts with Pfizer out for the next
...more
(27)
•••
Jkj193741
X
View Profile
View Bullboard History
Comment by
Jkj193741
on Feb 10, 2022 1:38pm
RE:Our blockbuster,,,,,
FOR SURE! AMEN AND AMEN! Jk
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 10, 2022 1:05pm
RE:Our blockbuster,,,,,
,,,I read where Koo has posted the short numbers on the other board. Seems it has increased since the good news of dosing,,,RVX has over 1.2 million shares out on the short side,,,,,,that could be
...more
(13)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Feb 10, 2022 12:06pm
Our blockbuster,,,,,
,,continues to be a ballbuster,,,,,,,,the lack of interest haunts this company ,,,,cuz no one out there believes Pinocchio,,,,,nor should they,,,,,,,we need Kulikowski,,,or Sweeney,,,,,,or Wong
...more
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 08, 2022 2:27pm
RE:Molnupiravir Sales
aacchhhh,,,,,,it would be awesome,,but chances are,, they will mumble and fumble and bumble the trial,,,,,,then scratch their nut sacks, (except for Ewelina),,,and tell us the trial was not designed
...more
(75)
•••
QualityTest
X
View Profile
View Bullboard History
Post by
QualityTest
on Feb 08, 2022 12:22pm
Molnupiravir Sales
Merck is estimating sales of 5-6 billion this year from their not-that-great drug. Pfizer is estimating sales of 22 billion for paxlovid. Would be nice if RVX could show ANY signs of this trial
...more
(0)
•••
elviradyer208
X
View Profile
View Bullboard History
Post by
elviradyer208
on Feb 08, 2022 12:54am
India will soon provide 5G fast internet network
The Indian government is targeting the auction of 5G mobile internet network spectrum to begin in March. With this, the internet network will be activated immediately to serve the Hindustan
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study